Domestic vaccines in March 2010 - vaccine production unit opened within Institute "Torlak"

Source: Novosti Tuesday, 22.12.2009. 12:54
Comments
Podeli

(Tomica Milosavljević and Ranko Dakić)

- Production of vaccines against flu in Serbia will start next year - it was said on Monday (December 21, 2009) at the opening of the unit for production of vaccines within Immunology and Virology Institute "Torlak".

According to the words of CEO of the Institute, Ranko Dakić, trial production should start in January, while the beginning of regular production is scheduled for March.

- If the vaccines against flu in 2010 are trivalent, the capacity of production will amount to 2m doses. If the vaccines are monovalent, than the capacity will amount to 6m doses - Dakić explained.

- World Health Organization will define the contents of the new seasonal vaccine against flu in February 2010.

The Minister of Health, Prof. Dr. Tomica Milosavljević, who cut the ribbon, said that the opening of the unit was very important event, not only for the Institute, but also for domestic health system, because the citizens of Serbia will be able to receive vaccines produced in "Torlak" already in autumn 2010:

- The race with time, technology and science is starting today, and we do have people for that race.

The state invested 2.7m EUR in construction of the new unit for production of vaccines, while "Torlak" invested 305,000 EUR. The Institute should also invest another 300,000 EUR in procurement of materials and equipment.
Comments
Your comment
Full information is available only to commercial users-subscribers and it is necessary to log in.

Forgot your password? Click here HERE

For free test use, click HERE

Follow the news, tenders, grants, legal regulations and reports on our portal.
Registracija na eKapiji vam omogućava pristup potpunim informacijama i dnevnom biltenu
Naš dnevni ekonomski bilten će stizati na vašu mejl adresu krajem svakog radnog dana. Bilteni su personalizovani prema interesovanjima svakog korisnika zasebno, uz konsultacije sa našim ekspertima.